Mixed antimony(V) complexes with different sugars to modulate the oral bioavailability of pentavalent antimonial drugs

Previous studies have shown that the association of the drug meglumine antimoniate (MA) with β-cyclodextrin can improve its bioavailability by the oral route. In this work, ribose and maltose were investigated for their ability to form mixed or association complexes with MA, release MA and modulate...

Full description

Saved in:
Bibliographic Details
Published in:Molecules (Basel, Switzerland) Vol. 19; no. 5; pp. 5478 - 5489
Main Authors: Ferreira, Weverson A, Islam, Arshad, Andrade, Aretha Priscilla S, Fernandes, Flaviana R, Frézard, Frédéric, Demicheli, Cynthia
Format: Journal Article
Language:English
Published: Switzerland MDPI 28-04-2014
MDPI AG
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Previous studies have shown that the association of the drug meglumine antimoniate (MA) with β-cyclodextrin can improve its bioavailability by the oral route. In this work, ribose and maltose were investigated for their ability to form mixed or association complexes with MA, release MA and modulate the serum levels of Sb after oral administration in mice. Analysis of the MA/ribose composition by high performance liquid chromatography coupled to mass spectrometry (LCMS-IT-TOF) revealed the presence of mixed meglumine-Sb-ribose and Sb-ribose complexes. Analysis of the MA/maltose composition suggested the formation of MA-maltose association compounds. Circular dichroism characterization of these compositions following dilution in water at 37 °C suggested a partial and slow dissociation of the association compounds. When the MA/ribose composition was administered orally and compared to MA, the serum concentration of Sb was significantly lower after 1 h and greater after 3 h. On the other hand, the MA/maltose composition showed similar serum Sb concentration after 1 h and higher level of Sb after 3 h, when compared to MA. In conclusion, the present study has demonstrated the formation of mixed or association complexes of MA with sugars, such as maltose and ribose, which promoted sustained serum level of Sb after oral administration.
AbstractList Previous studies have shown that the association of the drug meglumine antimoniate (MA) with β-cyclodextrin can improve its bioavailability by the oral route. In this work, ribose and maltose were investigated for their ability to form mixed or association complexes with MA, release MA and modulate the serum levels of Sb after oral administration in mice. Analysis of the MA/ribose composition by high performance liquid chromatography coupled to mass spectrometry (LCMS-IT-TOF) revealed the presence of mixed meglumine-Sb-ribose and Sb-ribose complexes. Analysis of the MA/maltose composition suggested the formation of MA-maltose association compounds. Circular dichroism characterization of these compositions following dilution in water at 37 °C suggested a partial and slow dissociation of the association compounds. When the MA/ribose composition was administered orally and compared to MA, the serum concentration of Sb was significantly lower after 1 h and greater after 3 h. On the other hand, the MA/maltose composition showed similar serum Sb concentration after 1 h and higher level of Sb after 3 h, when compared to MA. In conclusion, the present study has demonstrated the formation of mixed or association complexes of MA with sugars, such as maltose and ribose, which promoted sustained serum level of Sb after oral administration.
Author Demicheli, Cynthia
Andrade, Aretha Priscilla S
Ferreira, Weverson A
Islam, Arshad
Fernandes, Flaviana R
Frézard, Frédéric
AuthorAffiliation 1 Department of Chemistry, Institute of Exact Sciences – Federal University of Minas Gerais (UFMG), Av. Antônio Carlos 6627, Belo Horizonte 31270-901, MG, Brazil
2 Department of Physiology and Biophysics, Institute of Biological Sciences – Federal University of Minas Gerais (UFMG), Av. Antônio Carlos 6627, Belo Horizonte 31270-901, MG, Brazil
AuthorAffiliation_xml – name: 2 Department of Physiology and Biophysics, Institute of Biological Sciences – Federal University of Minas Gerais (UFMG), Av. Antônio Carlos 6627, Belo Horizonte 31270-901, MG, Brazil
– name: 1 Department of Chemistry, Institute of Exact Sciences – Federal University of Minas Gerais (UFMG), Av. Antônio Carlos 6627, Belo Horizonte 31270-901, MG, Brazil
Author_xml – sequence: 1
  givenname: Weverson A
  surname: Ferreira
  fullname: Ferreira, Weverson A
  organization: Department of Chemistry, Institute of Exact Sciences - Federal University of Minas Gerais (UFMG), Av. Antônio Carlos 6627, Belo Horizonte 31270-901, MG, Brazil
– sequence: 2
  givenname: Arshad
  surname: Islam
  fullname: Islam, Arshad
  organization: Department of Chemistry, Institute of Exact Sciences - Federal University of Minas Gerais (UFMG), Av. Antônio Carlos 6627, Belo Horizonte 31270-901, MG, Brazil
– sequence: 3
  givenname: Aretha Priscilla S
  surname: Andrade
  fullname: Andrade, Aretha Priscilla S
  organization: Department of Chemistry, Institute of Exact Sciences - Federal University of Minas Gerais (UFMG), Av. Antônio Carlos 6627, Belo Horizonte 31270-901, MG, Brazil
– sequence: 4
  givenname: Flaviana R
  surname: Fernandes
  fullname: Fernandes, Flaviana R
  organization: Department of Physiology and Biophysics, Institute of Biological Sciences - Federal University of Minas Gerais (UFMG), Av. Antônio Carlos 6627, Belo Horizonte 31270-901, MG, Brazil
– sequence: 5
  givenname: Frédéric
  surname: Frézard
  fullname: Frézard, Frédéric
  organization: Department of Physiology and Biophysics, Institute of Biological Sciences - Federal University of Minas Gerais (UFMG), Av. Antônio Carlos 6627, Belo Horizonte 31270-901, MG, Brazil
– sequence: 6
  givenname: Cynthia
  surname: Demicheli
  fullname: Demicheli, Cynthia
  email: demichel@netuno.lcc.ufmg.br
  organization: Department of Chemistry, Institute of Exact Sciences - Federal University of Minas Gerais (UFMG), Av. Antônio Carlos 6627, Belo Horizonte 31270-901, MG, Brazil. demichel@netuno.lcc.ufmg.br
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24786687$$D View this record in MEDLINE/PubMed
BookMark eNplkctuFDEQRS0URB7wAWyQl7CY4Hd3b5BQxCNSEBtg26q2q2ccudsj2z3J_D0OE6JEWVXpVt1TKt1TcjTHGQl5y9m5lB37OMWAdgmYece0Vk37gpxwJdhKMtUdPeqPyWnO14wJrrh-RY5F3TWmbU7I7oe_RUdhLn6K8_79nw_Uxmkb8BYzvfFlQ50fR0w4F5qXNaRMS6RTdEuAgrRskMYEgQ4-wg58gMEHX_Y0jnRbPVULd9Z7vq-bLi3r_Jq8HCFkfHNfz8jvr19-XXxfXf38dnnx-WplldFl5ZTpRiWFkg6NlVpAbQQXuuqta3GADqzRjRHKORjagUmOjeJWSjRdw-QZuTxwXYTrfpv8BGnfR_D9PyGmdQ-peBuw58JAKwcQA3eKQaUjY-PQctQWGyYq69OBtV2GCZ2tf9XPn0CfTma_6ddx1xvRMKN1BfADwKaYc8LxwctZfxdo_yzQ6nn3-OiD43-C8i82hqRb
CitedBy_id crossref_primary_10_3390_molecules28134959
crossref_primary_10_1016_j_ecoenv_2022_113317
crossref_primary_10_1016_j_ica_2018_02_005
crossref_primary_10_1016_j_etap_2023_104160
crossref_primary_10_1016_j_poly_2015_05_004
crossref_primary_10_1071_EN19156
crossref_primary_10_1111_cbdd_13757
crossref_primary_10_1016_j_chemosphere_2023_138494
crossref_primary_10_2217_nnm_2019_0095
Cites_doi 10.3390/molecules14072317
10.1007/s00216-006-0456-8
10.1023/A:1009200330741
10.1007/s10534-006-0001-4
10.1002/aoc.425
10.1093/clind/24.4.684
10.1093/cid/cis474
10.1128/AAC.48.1.100-103.2004
10.1016/j.ijpharm.2007.06.029
10.1002/bdd.695
10.1128/AAC.00639-13
10.1016/S0304-4165(02)00198-8
10.1016/j.ijpharm.2006.06.014
10.1056/NEJMoa021556
10.1016/j.jinorgbio.2007.10.010
10.1016/j.ica.2005.09.003
10.1371/journal.pone.0035671
10.1517/17425247.2010.529897
ContentType Journal Article
Copyright 2014 by the authors. 2014
Copyright_xml – notice: 2014 by the authors. 2014
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
5PM
DOA
DOI 10.3390/molecules19055478
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
DatabaseTitleList
MEDLINE

CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: http://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 1420-3049
EndPage 5489
ExternalDocumentID oai_doaj_org_article_126a83ba2b1d40ad8ee00fb81e5ce702
10_3390_molecules19055478
24786687
Genre Journal Article
GroupedDBID ---
0R~
123
2WC
3V.
53G
5VS
7X7
88E
8FE
8FG
8FH
8FI
8FJ
A8Z
AADQD
AAFWJ
AAHBH
ABDBF
ABJCF
ABUWG
ACGFO
ACIWK
ACPRK
AEGXH
AENEX
AFKRA
AFPKN
AFRAH
AFZYC
AIAGR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BBNVY
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CGR
CS3
CUY
CVF
D1I
DIK
DU5
E3Z
EBD
ECM
EIF
EMOBN
ESTFP
ESX
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
HZ~
I09
IPNFZ
KB.
KQ8
LK8
M1P
M7P
MODMG
M~E
NPM
O-U
O9-
OK1
P2P
PDBOC
PIMPY
PQQKQ
PROAC
PSQYO
RIG
RPM
SV3
TR2
TUS
UKHRP
~8M
AAYXX
CITATION
5PM
ID FETCH-LOGICAL-c465t-d469f43243de6c352a3de21254698d8eba9ac657624ddab8b031e741c33e69703
IEDL.DBID RPM
ISSN 1420-3049
IngestDate Tue Oct 22 15:04:40 EDT 2024
Tue Sep 17 21:27:22 EDT 2024
Thu Nov 21 23:20:06 EST 2024
Sat Sep 28 08:39:21 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c465t-d469f43243de6c352a3de21254698d8eba9ac657624ddab8b031e741c33e69703
Notes These authors contributed equally to this work.
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6270655/
PMID 24786687
PageCount 12
ParticipantIDs doaj_primary_oai_doaj_org_article_126a83ba2b1d40ad8ee00fb81e5ce702
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6270655
crossref_primary_10_3390_molecules19055478
pubmed_primary_24786687
PublicationCentury 2000
PublicationDate 20140428
PublicationDateYYYYMMDD 2014-04-28
PublicationDate_xml – month: 4
  year: 2014
  text: 20140428
  day: 28
PublicationDecade 2010
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Molecules (Basel, Switzerland)
PublicationTitleAlternate Molecules
PublicationYear 2014
Publisher MDPI
MDPI AG
Publisher_xml – name: MDPI
– name: MDPI AG
References Demicheli (ref_18) 1999; 12
Martins (ref_9) 2008; 347
Ferreira (ref_14) 2006; 19
Demicheli (ref_13) 2006; 359
Demicheli (ref_11) 2010; 7
Demicheli (ref_17) 2003; 17
Martins (ref_6) 2006; 325
Frezard (ref_7) 2008; 102
Demicheli (ref_12) 2002; 1570
Sundar (ref_3) 2002; 347
Demicheli (ref_8) 2004; 48
Hansen (ref_16) 2006; 385
Sundar (ref_4) 2012; 55
Fernandes (ref_5) 2013; 57
Berman (ref_2) 1997; 24
Ribeiro (ref_10) 2010; 31
Alvar (ref_1) 2012; 7
Demicheli (ref_15) 2009; 14
References_xml – volume: 14
  start-page: 2317
  year: 2009
  ident: ref_15
  article-title: Pentavalent antimonials: New perspectives for old drugs
  publication-title: Molecules
  doi: 10.3390/molecules14072317
  contributor:
    fullname: Demicheli
– volume: 385
  start-page: 821
  year: 2006
  ident: ref_16
  article-title: Mass spectrometric identification and characterization of antimony complexes with ribose-containing biomolecules
  publication-title: Anal. Bioanal. Chem.
  doi: 10.1007/s00216-006-0456-8
  contributor:
    fullname: Hansen
– volume: 12
  start-page: 63
  year: 1999
  ident: ref_18
  article-title: Physico-chemical characterization of meglumine antimoniate
  publication-title: BioMetals
  doi: 10.1023/A:1009200330741
  contributor:
    fullname: Demicheli
– volume: 19
  start-page: 573
  year: 2006
  ident: ref_14
  article-title: Characterization of reactions of antimoniate and meglumine antimoniate with a guanine ribonucleoside at different pH
  publication-title: Biometals
  doi: 10.1007/s10534-006-0001-4
  contributor:
    fullname: Ferreira
– volume: 17
  start-page: 226
  year: 2003
  ident: ref_17
  article-title: Pentavalent organoantimonial derivatives: Two simple and efficient synthetic methods for meglumine antimonate
  publication-title: Appl. Organomet. Chem.
  doi: 10.1002/aoc.425
  contributor:
    fullname: Demicheli
– volume: 24
  start-page: 684
  year: 1997
  ident: ref_2
  article-title: Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/clind/24.4.684
  contributor:
    fullname: Berman
– volume: 55
  start-page: 543
  year: 2012
  ident: ref_4
  article-title: Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/cid/cis474
  contributor:
    fullname: Sundar
– volume: 48
  start-page: 100
  year: 2004
  ident: ref_8
  article-title: Oral delivery of meglumine antimoniate-beta-cyclodextrin complex for treatment of leishmaniasis
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.48.1.100-103.2004
  contributor:
    fullname: Demicheli
– volume: 347
  start-page: 102
  year: 2008
  ident: ref_9
  article-title: Enhanced oral delivery of antimony from meglumine antimoniate/β-cyclodextrin nanoassemblies
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2007.06.029
  contributor:
    fullname: Martins
– volume: 31
  start-page: 109
  year: 2010
  ident: ref_10
  article-title: Prolonged absorption of antimony(V) by the oral route from non-i nclusion meglumine antimoniate-beta-cyclodextrin conjugates
  publication-title: Biopharm. Drug Dispos.
  doi: 10.1002/bdd.695
  contributor:
    fullname: Ribeiro
– volume: 57
  start-page: 4229
  year: 2013
  ident: ref_5
  article-title: Amphiphilic antimony(V) complexes for oral treatment of visceral leishmaniasis
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.00639-13
  contributor:
    fullname: Fernandes
– volume: 1570
  start-page: 192
  year: 2002
  ident: ref_12
  article-title: Antimony(V) complex formation with adenine nucleosides in aqueous solution
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/S0304-4165(02)00198-8
  contributor:
    fullname: Demicheli
– volume: 325
  start-page: 39
  year: 2006
  ident: ref_6
  article-title: Mode of action of β-cyclodextrin as an absorption enhancer of the water-soluble drug meglumine antimoniate
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2006.06.014
  contributor:
    fullname: Martins
– volume: 347
  start-page: 1739
  year: 2002
  ident: ref_3
  article-title: Oral miltefosine for Indian visceral leishmaniasis
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa021556
  contributor:
    fullname: Sundar
– volume: 102
  start-page: 656
  year: 2008
  ident: ref_7
  article-title: New insights into the chemical structure and composition of the pentavalent antimonial drugs meglumine antimonate and sodium stibogluconate
  publication-title: J. Inorg. Biochem.
  doi: 10.1016/j.jinorgbio.2007.10.010
  contributor:
    fullname: Frezard
– volume: 359
  start-page: 159
  year: 2006
  ident: ref_13
  article-title: Synthesis and characterization of Sb(V)–adenosine and Sb(V)–guanosine complexes in aqueous solution
  publication-title: Inorg. Chim. Acta
  doi: 10.1016/j.ica.2005.09.003
  contributor:
    fullname: Demicheli
– volume: 7
  start-page: e35671
  year: 2012
  ident: ref_1
  article-title: Leishmaniasis worldwide and global estimates of its incidence
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0035671
  contributor:
    fullname: Alvar
– volume: 7
  start-page: 1343
  year: 2010
  ident: ref_11
  article-title: New delivery strategies for the old pentavalent antimonial drugs
  publication-title: Expert Opin. Drug Deliv.
  doi: 10.1517/17425247.2010.529897
  contributor:
    fullname: Demicheli
SSID ssj0021415
Score 2.1893835
Snippet Previous studies have shown that the association of the drug meglumine antimoniate (MA) with β-cyclodextrin can improve its bioavailability by the oral route....
SourceID doaj
pubmedcentral
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 5478
SubjectTerms Administration, Oral
Animals
Antimony - administration & dosage
Antimony - chemistry
Biological Availability
Carbohydrates - administration & dosage
Carbohydrates - chemistry
Circular Dichroism
cyclodextrin
Cyclodextrins
Humans
leishmaniasis
maltose
Meglumine - administration & dosage
Meglumine - chemistry
Meglumine Antimoniate
Mice
oral
Organometallic Compounds - administration & dosage
Organometallic Compounds - chemistry
pentavalent antimonial drugs
ribose
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NT4MwFG90F70Yv8Wv9OBBTcigQIHjPrPL1GRqvJGWlkkywQxYtv_eV2DLiAcv3ho-SvN-Le89-vj9ELqDtcydyLJ1n4Rctx0hdM4jVxfCt4UwuE-J-t95NHGfPrz-QNHkbKS-VE1YRQ9cGa5tEso8izPCTWEbTHhSGkbEPVM6oXRrGkmDrpOpOtUywS9Ve5gWJPXtr0pqVmbg_hzFYNXwQiVZ_5YHalZHbrmb4SE6qONE3KnGd4R2ZHKM9nprebYTtBjHSylwJ8nB2snq_v0Bq7U9k0uZYfV1Ffdr7ZMcT4op5K84T_E4FUqvS2KI-_AzPBd345QtWDyr-LpXOI3wi6onhxmobq37h1mK-_Nimp2it-HgtTfSaxEFPbSpk-sC8t9I0e5ZQtIQwi0GDfBXjpKOBGty5rOQQtZBABvGPQ6rXEKYEVqWpD68D85QK0kTeYEws6KIMBr5BgMbUsZMtekqXQ5RhAttDT2ujRp8V1wZAeQYCoHgFwIa6iqzby5UNNflAQA_qMEP_gJfQ-cVVptuCHRNqedqyG2g2HhO80wSf5a02pSoLV_n8j8GdoX2IbIqS3yId41a-byQN2g3E8VtOVF_AJzf8vM
  priority: 102
  providerName: Directory of Open Access Journals
Title Mixed antimony(V) complexes with different sugars to modulate the oral bioavailability of pentavalent antimonial drugs
URI https://www.ncbi.nlm.nih.gov/pubmed/24786687
https://pubmed.ncbi.nlm.nih.gov/PMC6270655
https://doaj.org/article/126a83ba2b1d40ad8ee00fb81e5ce702
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb5tAEB7VvjSXKE3zcNNae-ghiUQMCyxwTOxEubix5DbKDe2yi4tkQ2TjKP73neFh2cqtJ1bAPrQzy8zHzn4D8BPXsvJT17MinijL87W2lEoDS-vI09pWkeB03vlxGvx6CUf3RJPjt2dhqqD9RGU3-Xxxk2d_q9jK10UyaOPEBpPxUHDanPMHHeigb9hC9AZlOWiS6u1LF_H8YFFnmTUrtHw-kVcR_S9ehKAouh1bVFH279ih_RjJHaPzcASHjbfIbutRfYFPJj-Gz8M2SdtXeBtn70az27zEOc83l89XjFb43LybFaN_rGzUZEAp2XQ9QxTLyoKNC01ZuwxD7489Yb_sLivkm8zmNWv3hhUpm1BUOeohVW3aR11lo-V6tjqBPw_3v4ePVpNKwUo84ZeWRhScEvmeq41I0OmSWECr5VMCSR0aJSOZCMQeHCUkVahwrRt0NhLXNSLCr8IpdPMiN-fApJumXIo0siVOp5DSoa1XEyj0JQIs9-C6ndT4tWbMiBFpkDDiD8LowR1N-_ZFIruubhTLWdyIPHa4kKGrJFeO9myJwzW2narQMX5iApv34KyW1baZVsA9CPakuNfP_hPUtYpcu9Gtb_9d8wIO0Kmqont4-B265XJtfkBnpdf9CvD3K3X9ByCJ884
link.rule.ids 230,315,729,782,786,866,887,2106,27933,27934,53800,53802
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT-MwEB4t7IG9LLuwj8Ky-MABVgpNnMRJjtCCiqCAxEPcIjt2upHaBLUpgn_PTB6oFTdOseLYsfKNPTPx-BuAPZzLyk9dz4p4oizP19pSKg0srSNPa1tFgtN558FNcPkQ9k-IJsdvz8JUQfuJyg7z8eQwz_5XsZWPk6Tbxol1r4c9wWlzzu-uwGecr7bdOumNn-WgUqo3MF306LuTOs-smaHu84m-igiA8SIExdEtaKOKtH9BEy1HSS6ondP1Dw74G3xt7Ex2VFd_h08m34C1XpvebROehtmz0ewoLxGt_GX__oDR2jA2z2bG6O8s6ze5U0p2Mx-h_8vKgg0LTfm-DEO7kV3heNlxVsgnmY1rvu8XVqTsmuLRUYKpadM_SjnrT-ej2Q-4Oz257Q2sJgmDlXjCLy2N_nNKtH2uNiJBc01iAfWdT6kndWiUjGQi0GvhiK1UocJVwqCZkriuERGuJz9hNS9y8xuYdNOUS5FGtkQYhJQObdqaQKEVEmC5A_9aMOLHmmsjRh-FQIzfgdiBY4Lr7UGiya5uFNNR3Hz72OFChq6SXDnasyUO19h2qkLH-IkJbN6BXzXGb920gtGBYAn9pfcs1yDoFS13A_LWh1vuwtrgdngRX5xdnm_DFzTNqhghHv6B1XI6NzuwMtPzv5WwvwIH6whv
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEB7RIgGX8qbhuQcOgOTaXttr-9gmjYogJVIBcbN2vbvBUmJHiVO1_54ZP6JE3ODklb0v-ZvdmfGOvwF4j2tZRTYInZTnygkjrR2lbOxonYZaeyoVnP53vriKL38lo3Oiydmm-mqC9nNVnJTzxUlZ_G5iK5eL3O3jxNzpZCg4Hc5F7lJb9wDu4pr1eO-od76Wj4qpPcQM0Kt3F22uWbNG_RcRhRWRAONFCIql29FIDXH_jjbaj5TcUT3jh_8x6Udw1Nmb7LSt8hjumPIJ3B_2ad6ewvWkuDGanZY1olbefvj5kdEeMTc3Zs3oKy0bdTlUana1maEfzOqKTSpNeb8MQ_uRfcM5s7OikteymLe837essmxKcekoydS06x-lnY1Wm9n6GfwYn38fXjhdMgYnD0VUOxr9aEv0fYE2IkezTWIB9V5EKSh1YpRMZS7Qe-GIsVSJwt3CoLmSB4ERKe4rz-GwrEpzDEwG1nIpbOpJhEJI6dPhrYkVWiMxlgfwqQckW7acGxn6KgRk9heQAzgjyLYViS67uVGtZln3_jOfC5kESnLl69CTOF3jeVYlvolyE3t8AC9anLfd9MIxgHhPAvbG2X-CwDf03B3QL_-55Tu4Nx2Ns6-fL7-8ggdooTWhQjx5DYf1amPewMFab9428v4HRRwK7w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mixed+Antimony%28V%29+Complexes+with+Different+Sugars+to+Modulate+the+Oral+Bioavailability+of+Pentavalent+Antimonial+Drugs&rft.jtitle=Molecules+%28Basel%2C+Switzerland%29&rft.au=Ferreira%2C+Weverson+A.&rft.au=Islam%2C+Arshad&rft.au=Andrade%2C+Aretha+Priscilla+S.&rft.au=Fernandes%2C+Flaviana+R.&rft.date=2014-04-28&rft.pub=MDPI&rft.eissn=1420-3049&rft.volume=19&rft.issue=5&rft.spage=5478&rft.epage=5489&rft_id=info:doi/10.3390%2Fmolecules19055478&rft_id=info%3Apmid%2F24786687&rft.externalDBID=PMC6270655
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1420-3049&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1420-3049&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1420-3049&client=summon